/주식/HRMY
HRMY

HRMY

USD

Harmony Biosciences Holdings Inc. Common Stock

$30.720+1.470 (5.026%)

실시간 가격

Healthcare
생명공학
미국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$29.250

고가

$30.890

저가

$27.660

거래량

1.44M

기업 기본 정보

시가총액

1.8B

산업

생명공학

국가

United States

거래 통계

평균 거래량

0.82M

거래소

NGM

통화

USD

52주 범위

저가 $25.52현재가 $30.720고가 $40.93

관련 뉴스

BusinessWire

Harmony Biosciences Reports Strong Q3 2025 Financial Results; Recently Raised 2025 Revenue Guidance to $845-$865M

WAKIX® (pitolisant) Franchise Delivers Net Revenue of $239M in Q3 2025 (+29% YoY Growth) Record Increase in Average Number of Patients of Approximately 500 to Achieve 8,100 Average Patients in Q3 2025 Strong Cash

더 보기
Harmony Biosciences Reports Strong Q3 2025 Financial Results; Recently Raised 2025 Revenue Guidance to $845-$865M
BusinessWire

Harmony Biosciences Preannounces Strong Q3 2025 WAKIX Performance; Raises 2025 Revenue Guidance

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) today announced preliminary results for Q3 2025, highlighted by the following: WAKIX® (pitolisant) franchise delivered net revenue of approximately $239M in Q3

더 보기
Harmony Biosciences Preannounces Strong Q3 2025 WAKIX Performance; Raises 2025 Revenue Guidance